دورية أكاديمية

O12 - Tumor Response by Baseline Metastases in Patients (Pts) With Renal Cell Carcinoma (RCC) Treated with Lenvatinib (L) Plus Pembrolizumab (P) vs Sunitinib (S): Post Hoc Analysis of the CLEAR Trial

التفاصيل البيبلوغرافية
العنوان: O12 - Tumor Response by Baseline Metastases in Patients (Pts) With Renal Cell Carcinoma (RCC) Treated with Lenvatinib (L) Plus Pembrolizumab (P) vs Sunitinib (S): Post Hoc Analysis of the CLEAR Trial
المؤلفون: Grünwald, V., McKay, R.R., Buchler, T., Masatoshi, E., Park, S.H., Takagi, T., Zanetta, S., Keizman, D., Suárez, C., Négrier, S., Lee, J.L., Santini, D., Bedke, J., Staehler, M., Kollmannsberger, C., Choueiri, T., Motzer, R., Burgents, J., Okpara, C., Powles, T.
المصدر: In European Urology Open Science November 2023 57 Supplement 1:S15-S16
قاعدة البيانات: ScienceDirect
الوصف
تدمد:26661683
DOI:10.1016/S2666-1683(23)01307-1